world mapExperience and Collaboration Squared. In February 2013, Synteract acquired Harrison Clinical Research – expanding our services and strength to the Power of Two – two excellent CROs that, together as one, provide global, full-service clinical trial services. Now SynteractHCR can provide multinational services from 16 countries worldwide. More…

Welcome

SynteractHCR is a full-service CRO with more than two decades of success delivering customized Phase I-IV clinical trial solutions, contributing to numerous product approvals across multiple therapeutic areas. More...

Latest News

|

CEO Wendel Barr provides insight into SynteractHCR’s vision, expansion and plans to go global. Read the feature article in Clinical Leader. More...

May 06, 2013

SynteractHCR will be exhibiting and speaking at two May industry events, Outsourcing in Clinical Trials Southeast and Outsourcing in Clinical Trials in Europe. More...

May 02, 2013

CEO Wendel Barr was featured in C-Suite: CROs in the April issue of PharmaVoice. Wendel discusses how to increase trial efficiency with intelligent clinical development. More...

April 15, 2013

Watch CEO Wendel Barr on UT-TV

SynteractHCR Wendel Barr was interviewed on ‘Primetime with Taylor Baldwin.’ He discusses the vision for SynteractHCR, the acquisition of Harrison Clinical Research, and what it all means for the San Diego life sciences community.
Watch video